Journal of Jilin University Medicine Edition ›› 2015, Vol. 41 ›› Issue (02): 429-432.doi: 10.13481/j.1671-587x.20150245
Previous Articles Next Articles
1
Received:2014-03-10
Online:2015-03-28
Published:2015-04-04
CLC Number:
| [1] Wang XY,Yin Y,Yuan H,et al. Musashi 1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the wnt and notch pathways [J]. Mol Cell Biol,2008,28(11):3589-3599.[2] Nakamura M,Okano H,Blendy JA,et al. A neural RNA-binding protein required for Drosophila adult external sensory organ development [J]. Neuron,1994,13(1):67-81.[3] Sakakibara S,Imai T,Hamaguchi K,et al. A neural RNA-binding protein highly enriched in the mammalian CNS stem cell [J]. Dev Biol,1996,176(2):230-242.[4] Ratti A,Fallini C,Cova L,et al. A role for the ELAV RNA-binding proteins in neural stem cells:stabilization of Msi1 mRNA[J]. J Cell Sci,2006,119(Pt7):1442-1452.[5] Okano H,Kawahara H,Toriya M,et al. Function of RNA-binding protein Musashi 1 in stem cells[J]. Exp Cell Res,2005,306(2):349-356.[6] Glazer RI,Wang XY,Yuan H,et al. Musashi1:A Stem Cell Marker No Longer in Search of a Function[J]. Cell Cycle,2008,7(17):2635-2639.[7] Imai T,Tokunaga A,Yoshida T,et al. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA[J]. Mol Cell Biol,2001,21(12):3888-3900.[8] Okabe M,Imai T,Kurusu M,et al. Translational repression determines a neuronal potential in Drosophila asymmetric cell division[J]. Nature,2001,411(6833):94-98.[9] Kayahara T,Sawada M,Takaishi S,et al. Candidate markers for stem and early progenitor cells,Musashi-1 and Hesl,are expressed in crypt base columnar cells of mouse small intestine [J]. FEBS Lett,2003,535(1-3):131-135.[10] Battelli C,Nikopoulos GN,Mitchell JG,et al. The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1[J]. Mol Cell Neurosci,2006,31(1):85-96.[11] Abreu RS, Sanchez-Diaz PC,Christine V,et al. Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes[J]. J Biol Chem,2009,284(18):12125-12135.[12] Toda M,Iizuka Y,Yu W,et al. Expression of the neural RNA-binding protein Musashi1 in human gliomas[J]. Glia,2001,34(1):1-7.[13] Kanemura Y,Mori K,Sakakibara S,et al. Musashi1,an evolutionarily conserved neural RNA-binding protein,is a versatile marker of human glioma cells in determining their cellular origin,malignancy,and proliferative activity[J]. Differentiation,2001,68(2-3):141-152.[14] Yokota N,Mainprize TG,Taylor MD,et al. Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization[J]. Oncogene,2004,23(19):3444-3453.[15] Nakano A,Kanemura Y,Mori K,et al. Expression of the Neural RNA-binding protein Musashi1 in pediatric brain tumors[J]. Pediatr Neurosurg,2007,43(4):279-284.[16] Boon K,Edwards JB,Siu IM,et al.Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes[J]. Oncogene,2003,22(48):7687-7694.[17] Ma YH,Mentlein R,Knerlich F,et al.Expression of stem cell markers in human astrocytomas of different WHO grades[J]. J Neurooncol,2008,86(1):31-45.[18] Seigel GM,Hackam AS,Ganguly A,et al. Human embryonic and neuronal stem cell markers in retinoblastoma[J]. Mol Vis,2007,13:823-832.[19] Sanchez-Diaz PC,Burton TL,Burns SC,et al. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy [J]. BMC Genetics,2008,9:280-291.[20] Shu HJ,Saito T,Watanabe H,et al. Expression of the Musashi1 gene encoding the RNA-binding protein in human hepatoma cell lines [J]. Biochem Biophys Res Commun,2002,293(1):150-154.[21] Fan LF,Dong WG,Jiang CQ,et al. Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas [J]. Int J Colorect Dis,2010,25(1):17-23.[22] Li D,Peng X,Yan D,et al. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer [J].Ann Sug Oncol,2011,18(7):2074-2083.[23] Bobryshev YV,Freeman AK,Botelho NK,et al. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma [J]. Dis Esophagus,2010,23(7):580-589.[24] Vega KJ,May R,Sureban SM,et al. Identification of the putative intestinal stem cell marker DCAMKL-1 in Barrett's esophagus and esophageal adenocarcinoma [J]. Gastroenterol Hepatol,2012,27(4):773-780.[25] Schmuck R,Warneke V,Behrens HM,et al. Genotypic and phenotypic characterization of side population of gastric cancer cell lines [J]. Am J Pathol,2011,178(4):1792-1804.[26] Wang T,Ong CW,Shi J,et al. Sequential expression of putative stem cell markers in gastric carcinogenesis [J]. Br J Cancer,2011,105(5):658-665.[27] Lewis A,Segditsas S,Deheragoda M,et al. Severe polyposis in Apc(1322 T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5 [J]. Gut,2010,59(12):1680-1686.[28] Todaro M,Alea MP,Di Stefano AB,et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4 [J]. Cell Stem Cell,2007,1(4):389-402.[29] Li YQ,Wu CT,Wu Y,et al. The expression of Msi-1 and its significance in small intestinal mucosa severely damaged by high-dose 5-FU [J]. Dig Dis Sci,2008,53(9):2436-2442.[30] Wang XY,Penalva LO,Yuan HY,et al. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival [J]. Mol Cancer,2010,9:221.[31] Moreira AL,Gonen M,Rekhtman N,et al. Progenitor stem cell marker expression by pulmonary carcinomas [J]. Mod Pathol,2010,23(6):889-895.[32] Kanai R,Eguchi K,Takahashi M,et al. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer-expression of an RNA-binding protein,Musashi1,as a marker for the tailored gene therapy[J]. J Gene Med,2006,8(11):1329-1340.[33] Wang XY,Yu H,Linnoila RI,et al.Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer[J]. Oncotarget,2013,4(5):739-750.[34] Ye F,Zhou C,Cheng Q,et al. Stem-cell-abundant proteins Nanog,nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells[J].BMC Cancer,2008,8:108.[35] Gotte M,Wolf M,Staebler A,et al. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma[J]. J Pathol,2008,215(3):317-329.[36] Cervello I,Mirantes C,Santamaria X,et al. Stem cells in human endometrium and endometrial carcinoma[J]. Int J Gynecol Pathol,2011,30(4):317-327.[37] Okuno K,Ohta S,Kato H,et al. Expression of neural stem cell markers in malignant rhabdoid tumor cell lines[J]. Oncol Rep,2010,23(2):485-492.[38] Ravindran G,Devaraj H. Aberrant expression of CD133 and musashi-1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors[J]. Head Neck,2012,34(8):1129-1135.[39] Thill M,Berna MJ,Grierson R,et al. Expression of CD133 and other putative stem cell markers in uveal melanoma[J]. Melanoma Res,2011,21(5):405-416.[40] Nikpour P,Baygi ME,Steinhoff C,et al.The RNA binding protein musashi1 regulates apoptosis,gene expression and stress granule formation in urothelial carcinoma cells[J]. J Cell Mol Med,2011,15(5):1210-1224. |
| [1] | Lina ZHANG,Zhesi MENG,Long BA,Jun MENG. Research progress in relationship between cell division cycle protein 6 and occurrence and development of tumor [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 847-853. |
| [2] | Zhipeng PAN,Le WANG,Weiwen HUANG,Zhen YI,Yuxuan GAO. Bioinformatics analysis and experimental validation based on screening and identification of diagnostic candidate genes of bone marrow mononuclear cells of acute myeloid leukemia patients and their impact on prognosis [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 791-805. |
| [3] | Xiaohui LIANG,Wenna LIU,Jianbo ZHAO. Bioinformatic analysis on PAQR3 expression in hepatocellular carcinoma and its correlations with T lymphocyte infiltration, immune checkpoint genes, and patient survival [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 781-790. |
| [4] | Gengfei CAO, SHAYA·Mahati,Junpeng GU,Weizheng JI, ASIHAER·Hasimu,Weixin REN. Differences in immune microenvironment between DEB-TACE and c-TACE in treatment of hepatocellular carcinoma and mechanism of TRADD-mediated Th17 differentiation [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 764-780. |
| [5] | Xin LIU,Yuyang ZHANG,Deling ZENG,Xiaoqin LIU,Lu ZHANG,Meiying LI,Hong CHEN,Bangrong CAO,Shiqi MA. Levels of KLRG1 +NK cells in peripheral blood of NSCLC patients and their clinical significances [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 746-754. |
| [6] | Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745. |
| [7] | Heqiang JIA,Lu PAN,Zhenjiang WANG,Jiayu LU,Dan WANG,Lifeng LIU,Ying DONG,Chunyan YU. Improving effect of Panaxatriol saponins on D-galactose-induced skeletal muscle aging of mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 730-737. |
| [8] | Yang LI,Shiyang LI,Hongmei ZHANG,Qianqian LIU,Yubing CHEN. Effect of NGFR gene expression differences on promotion of apoptosis of squamous cell carcinoma and adenocarcinoma cells by PD-1 inhibitor-activated T lymphocytes [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 680-693. |
| [9] | Xiao ZHOU,Haitao DAI,Yunshan DING,Linjie ZHANG,Nan WU. Network pharmacology analysis and in vitro experimental validation of anticancer effect of grape seed proanthocyanidins against oral squamous cell carcinoma [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 651-662. |
| [10] | Wei ZHOU,Yangyang HE,Youde WANG,Wenzhuo MA,Heng KANG. Effect of histone deacetylase 6 inhibitor ACY-241 on macrophage polarization and biological behaviors of esophageal cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 621-632. |
| [11] | Jie YU,Zongkang WANG,Xun LIU,Yanan YANG,Jin TAN. Effect of miR-153-3p/PGC-1α axis on apoptosis of oral squamous cell carcinoma cells by modulation of mitochondrial apoptosis pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 348-358. |
| [12] | Yao ZHENG,Mingxia FU,Weichen WANG,Weiwei CHEN,Yuchen HAN,Yu BAI,Jiajia AN. Effect of sodium selenite on biological behaviors of breast cancer doxorubicin-resistant MCF-7/ADR cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 410-417. |
| [13] | Yu ZHAO,Xiaoshuang HE,Xiaoyin DONG,Fengyi GAO,Jiageng HE. Regulatory effect of lncRNA urothelial carcinoembryonic antigen 1 on anoikis in human gastrointestinal stromal tumor cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 429-439. |
| [14] | Li ZHAI,Meng CHEN,Jianbo LUO,Aili ZHANG,Liangxiao WANG,Ying WEI,Xi ZHANG. Targeting relationship between miR-214-3p and EZH2 and its effects on proliferation, invasion, and apoptosis of ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 460-468. |
| [15] | Hong LI,Panpan YU,Zouyu ZHAO,Chongfeng SUN,Hui QIAO,Ping YANG. Expression of GSTO1 in ovarian cancer tissue and effect of N-glycosylation site mutations on biological behaviors of epithelial ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 469-482. |